OpenURL Connection Search

Select item for more details and to access through your institution.

Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study.
Published in:
Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 5, p. 945, doi. 10.1007/s00432-018-2604-x
By:
- Ross, David M.;
- Masszi, Tamas;
- Gómez Casares, María Teresa;
- Hellmann, Andrzej;
- Stentoft, Jesper;
- Conneally, Eibhlin;
- Garcia-Gutierrez, Valentin;
- Gattermann, Norbert;
- le Coutre, Philipp D.;
- Martino, Bruno;
- Saussele, Susanne;
- Giles, Francis J.;
- Radich, Jerald P.;
- Saglio, Giuseppe;
- Deng, Weiping;
- Krunic, Nancy;
- Bédoucha, Véronique;
- Gopalakrishna, Prashanth;
- Hochhaus, Andreas
Publication type:
Article
Effect of the tyrosine kinase inhibitor nilotinib in patients with hypereosinophilic syndrome/chronic eosinophilic leukemia: analysis of the phase 2, open-label, single-arm A2101 study.
Published in:
Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 12, p. 1985, doi. 10.1007/s00432-013-1529-7
By:
- Hochhaus, Andreas;
- le Coutre, Philipp D.;
- Kantarjian, Hagop M.;
- Baccarani, Michele;
- Erben, Philipp;
- Reiter, Andreas;
- McCulloch, Tracey;
- Fan, Xiaolin;
- Novick, Steven;
- Giles, Francis J.
Publication type:
Article
Combination of Asciminib+Nilotinib or Asciminib+Dasatinib in Previously Treated Chronic Myeloid Leukemia (CML) Patients: Phase 1 Study Results.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S290, doi. 10.1016/j.clml.2019.07.236
By:
- DeAngelo, Daniel J.;
- Mauro, Michael J.;
- Kim, Dong-Wook;
- Cortes, Jorge;
- Réa, Delphine;
- Hughes, Timothy P.;
- Minami, Hironobu;
- Breccia, Massimo;
- Talpaz, Moshe;
- Hochhaus, Andreas;
- Goh, Yeow Tee;
- Le Coutre, Philipp D.;
- Sondhi, Manu;
- Mishra, Kaushal;
- Hourcade-Potelleret, Florence;
- Vanasse, Gary;
- Aimone, Paola;
- Lang, Fabian
Publication type:
Article
Efficacy and Safety of Asciminib, a Specific Allosteric BCR-ABL1 Inhibitor Targeting the Myristoyl-Binding Site, in Patients with Chronic Myeloid Leukemia (CML) Carrying the T315I Mutation.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S289, doi. 10.1016/j.clml.2019.07.234
By:
- Deininger, Michael W.;
- Réa, Delphine;
- Lang, Fabian;
- Kim, Dong-Wook;
- Cortes, Jorge E.;
- Hughes, Timothy P.;
- Minami, Hironobu;
- Breccia, Massimo;
- DeAngelo, Daniel J.;
- Hochhaus, Andreas;
- Talpaz, Moshe;
- Goh, Yeow Tee;
- Le Coutre, Philipp D.;
- Etienne, Gabriel;
- Sondhi, Manu;
- Mishra, Kaushal;
- Aimone, Paola;
- Mauro, Michael J.
Publication type:
Article
Treatment-Free Remission (TFR) Following Frontline Nilotinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP): 192-Weeks Data from the ENESTfreedom Study.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S288, doi. 10.1016/j.clml.2019.07.232
By:
- Radich, Jerald P.;
- Ross, David M.;
- Masszi, Tamas;
- Gómez Casares, María Teresa;
- Hellmann, Andrzej;
- Stentoft, Jesper;
- Conneally, Eibhlin;
- Gutierrez, Valentin García;
- Gattermann, Norbert;
- Le Coutre, Philipp D.;
- Martino, Bruno;
- Saussele, Susanne;
- Giles, Francis J.;
- Saglio, Giuseppe;
- Sondhi, Manu;
- Mishra, Kaushal;
- Aimone, Paola;
- Hochhaus, Andreas
Publication type:
Article
Combination of Asciminib, a Novel and Specific BCR-ABL1 Inhibitor, Plus Imatinib in Previously Treated Chronic Myeloid Leukemia (CML) Patients: Phase 1 Study Results.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S287, doi. 10.1016/j.clml.2019.07.231
By:
- Talpaz, Moshe;
- Cortes, Jorge;
- Lang, Fabian;
- Kim, Dong-Wook;
- Réa, Delphine;
- Mauro, Michael J.;
- Minami, Hironobu;
- Breccia, Massimo;
- DeAngelo, Daniel J.;
- Hochhaus, Andreas;
- Goh, Yeow Tee;
- Le Coutre, Philipp D.;
- Sondhi, Manu;
- Mishra, Kaushal;
- Hourcade-Potelleret, Florence;
- Vanasse, Gary;
- Aimone, Paola;
- Hughes, Timothy P.
Publication type:
Article
ENESTfreedom 144-Week Update: Long-Term Treatment-Free Remission (TFR) Following Frontline Nilotinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S226, doi. 10.1016/j.clml.2018.07.099
By:
- Radich, Jerald P.;
- Masszi, Tamás;
- Gómez Casares, María Teresa;
- Hellmann, Andrzej;
- Stentoft, Jesper;
- Conneally, Eibhlin;
- Gutierrez, Valentín Garcia;
- Gattermann, Norbert;
- le Coutre, Philipp D.;
- Martino, Bruno;
- Saussele, Susanne;
- Giles, Francis J.;
- Ross, David M.;
- Saglio, Giuseppe;
- Sondhi, Manu;
- Acharyya, Suddhasatta;
- Chaturvedi, Shalini;
- Bédoucha, Véronique;
- Hochhaus, Andreas
Publication type:
Article
5-Year Updates from the Pivotal Phase 2 Ponatinib PACE Trial: Efficacy, Safety and Landmark Analysis in Heavily Pretreated Patients with Chronic-Phase Chronic Myeloid Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S307, doi. 10.1016/j.clml.2017.07.105
By:
- Cortes, Jorge E.;
- Kantarjian, Hagop M.;
- Pinilla-Ibarz, Javier;
- le Coutre, Philipp D.;
- Paquette, Ronald;
- Chuah, Charles;
- Nicolini, Franck E.;
- Talpaz, Moshe;
- Baccarani, Michele;
- Deininger, Michael W.;
- Hochhaus, Andreas;
- Hughes, Timothy P.;
- Shah, Neil P.;
- Lustgarten, Stephanie;
- Santillana, Sergio;
- Rivera, Victor M.;
- Clackson, Tim;
- Mueller, Martin C.
Publication type:
Article
Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial.
Published in:
Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-020-01004-y
By:
- Kreitman, Robert J.;
- Dearden, Claire;
- Zinzani, Pier Luigi;
- Delgado, Julio;
- Robak, Tadeusz;
- le Coutre, Philipp D.;
- Gjertsen, Bjørn T.;
- Troussard, Xavier;
- Roboz, Gail J.;
- Karlin, Lionel;
- Gladstone, Douglas E.;
- Kuptsova-Clarkson, Nataliya;
- Liu, Shiyao;
- Patel, Priti;
- Rotolo, Federico;
- Mitry, Emmanuel;
- Pastan, Ira;
- Giles, Francis
Publication type:
Article

Found: 9